{"SPADE_UN_11009": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2011/0159022 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2011_0159022_A1", "Patent Type": "Patent Application", "Publication Date": "2011-6-30", "Family Info": "CA2728459A1,CN102123731A,EP2296697A1,WO2009153463A1", "Patent Title": "Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine.", "Abstract": "A peptide derived from the Midkine protein, comprising at least one CD4+ T or CD8+ T epitope restricted by the HLA molecules predominant in the Caucasian population, or a polynucleotide encoding said peptide, as an anticancer vaccine or as a reagent for immunomonitoring of the cellular response against Midkine over the course of a cancer or of an anticancer treatment."}], "Sequence Information": {"SPADE ID": "SPADE_UN_11009", "Sequence": "TERVRLVTRHIYNREE", "Sequence Length": 16, "Peptide Name": "Sequence 34 from Patent US 20110159022", "Source": "Synthetic construct", "Biological Activity": ["Anticancer"], "Frequent Amino Acids": "RET", "Absent Amino Acids": "ACDFGKMOPQSUW", "Basic Residues": 5, "Acidic Residues": 3, "Hydrophobic Residues": 5, "Polar Residues": 11, "Positive Residues": 5, "Negative Residues": 3, "Mass": 2071.3, "PI": 8.44, "Net Charge": 2, "Hydrophobicity": -1.32, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_03199", "Similarity": 0.6666666666666666, "Sequence": "RRWRIVVERVRR"}, {"SPADE_ID": "SPADE_UN_01796", "Similarity": 0.6666666666666666, "Sequence": "VVIRAAIRRVRL"}, {"SPADE_ID": "SPADE_UN_02287", "Similarity": 0.6666666666666666, "Sequence": "ANNPLRVRL"}]}}}